Drugs Made In America Acquisition II Corp 的關鍵財務報表是什麼?
DMIIU 的關鍵財務比率是什麼?
Drugs Made In America Acquisition II Corp 的收入按細分市場或地理位置如何劃分?
Drugs Made In America Acquisition II Corp 是否盈利?
Drugs Made In America Acquisition II Corp 有負債嗎?
Drugs Made In America Acquisition II Corp 的流通股有多少?
關鍵數據
前收市價
$10.02
開盤價
$10.11
當日範圍
$10.08 - $10.25
52週區間
$9.93 - $10.8
交易量
8.1K
平均成交量
32.3K
每股盈餘 (TTM)
--
股息收益率
--
市值
$661.0M
什麼是 DMIIU?
Drugs Made In America Acquisition II Corp. operates as a blank check company. The company is headquartered in Fort Lauderdale, Florida. The company went IPO on 2025-09-25. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The firm intends to search for business combination targets in the pharmaceutical industry. The firm is neither engaged in any operations nor generated any revenues.